Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) - Global Forecast to 2023
“The global apoptosis assays market is projected to grow at a CAGR of 10.5%”
The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%. The rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs are the key drivers for market growth. However, high investments required for research and development is expected to restrain the growth of this market to a certain extent during the forecast period.
“The flow cytometry segment to witness the highest growth during the forecast period”
On the basis of detection technology, the apoptosis assays market is segmented into flow cytometry, cell imaging & microscopy, spectrophotometry, and other detection technologies. The cell imaging & microscopy segment is expected to register the highest CAGR during the forecast period. The increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research is the major factor driving the growth of this market segment.
“The stem cell research applications segment is expected to grow at the highest CAGR during the forecast period”
On the basis of application, the apoptosis assays market is segmented into drug discovery & development, basic research, stem cell research, and clinical & diagnostic application. The stem cell research applications segment is expected to witness the highest CAGR owing to the increasing number of stem cell research activities and rising investments in stem cell research. Also government initiatives are expected to increase the number of cell-based research activities, which in turn will support the growth of the stem cell application segment.
“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global apoptosis assays market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries. Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.
The breakdown of primary participants was as mentioned below:
Research Coverage:
The report analyzes the various apoptosis products and their adoption pattern. It aims at estimating the market size and future growth potential of the global apoptosis assays market for different segments such as products, detection technology, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%. The rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs are the key drivers for market growth. However, high investments required for research and development is expected to restrain the growth of this market to a certain extent during the forecast period.
“The flow cytometry segment to witness the highest growth during the forecast period”
On the basis of detection technology, the apoptosis assays market is segmented into flow cytometry, cell imaging & microscopy, spectrophotometry, and other detection technologies. The cell imaging & microscopy segment is expected to register the highest CAGR during the forecast period. The increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research is the major factor driving the growth of this market segment.
“The stem cell research applications segment is expected to grow at the highest CAGR during the forecast period”
On the basis of application, the apoptosis assays market is segmented into drug discovery & development, basic research, stem cell research, and clinical & diagnostic application. The stem cell research applications segment is expected to witness the highest CAGR owing to the increasing number of stem cell research activities and rising investments in stem cell research. Also government initiatives are expected to increase the number of cell-based research activities, which in turn will support the growth of the stem cell application segment.
“APAC is projected to witness the highest growth during the forecast period.”
North America is expected to account for the largest share of the global apoptosis assays market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries. Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.
The breakdown of primary participants was as mentioned below:
- By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation: C-level–35%, Director Level–25%, and Others–40%
- By Region: North America–45%, Europe–20%, Asia Pacific–30%, and RoW–5%
Research Coverage:
The report analyzes the various apoptosis products and their adoption pattern. It aims at estimating the market size and future growth potential of the global apoptosis assays market for different segments such as products, detection technology, applications, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global apoptosis assays market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global apoptosis assays market
- Market Development: Comprehensive information on the lucrative emerging regions by product, detection technology, application, end user, and region
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global apoptosis assays market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global apoptosis assays market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 APOPTOSIS ASSAYS MARKET OVERVIEW
4.2 APOPTOSIS ASSAYS MARKET: GEOGRAPHIC OVERVIEW (2017)
4.3 REGIONAL MIX: APOPTOSIS ASSAYS MARKET (2018–2023)
4.4 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY END USER & COUNTRY (2017)
4.5 APOPTOSIS ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence and prevalence of chronic and infectious diseases
5.2.1.2 Growing funding for cancer research
5.2.1.3 Growing cell-based research
5.2.1.4 Development of apoptosis-modulating drugs
5.2.2 RESTRAINTS
5.2.2.1 High investments required for research and development
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING ADOPTION OF APOPTOSIS-TARGETING THERAPY IN CANCER TREATMENT
6.2.2 TECHNOLOGICAL ADVANCEMENTS
6.2.2.1 Label-free detection and imaging of apoptosis
6.2.2.2 Microfluidic devices for the analysis of apoptosis
6.3 UNMET NEED
6.3.1 UNAVAILABILITY OF 3D APOPTOSIS ASSAYS
7 APOPTOSIS ASSAYS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.1.1 ASSAY KITS
7.1.1.1 Caspase assays
7.1.1.1.1 Caspase assays to dominate the assay kits market during the forecast period
7.1.1.2 Annexin V and cell permeability assays
7.1.1.2.1 Annexin V & cell permeability assays are among the most commonly used apoptosis assays due to their ability to bind to phosphatidylserine
7.1.1.3 DNA fragmentation assays
7.1.1.3.1 Ability to detect nuclear changes to drive the demand for DNA fragmentation assay kits
7.1.1.4 Mitochondrial assays
7.1.1.4.1 Merck, Thermo Fisher, Bio-Rad, and BD are among the key players in the mitochondrial assays segment
7.1.2 REAGENTS
7.1.3 INSTRUMENTS
7.1.4 MICROPLATES
8 APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY
8.1 INTRODUCTION
8.1.1 FLOW CYTOMETRY
8.1.1.1 Flow cytometry is the most popular apoptosis detection technology owing to its ability to provide quantitative multi-parametric analysis
8.1.2 CELL IMAGING AND MICROSCOPY
8.1.2.1 Ability to monitor cell physiology and examine complex cellular processes to drive the demand for cell imaging and microscopy technologies
8.1.3 SPECTROPHOTOMETRY
8.1.3.1 Lower instrument cost as compared to flow cytometers drives greater adoption of spectrophotometers in academic settings
8.1.4 OTHER DETECTION TECHNOLOGIES
9 APOPTOSIS ASSAYS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 DRUG DISCOVERY AND DEVELOPMENT
9.2.1 DRUG DISCOVERY AND DEVELOPMENT FORMS THE LARGEST APPLICATION MARKET FOR APOPTOSIS ASSAYS
9.3 CLINICAL AND DIAGNOSTIC APPLICATIONS
9.3.1 RISING PREVALENCE OF CANCER, BLOOD-RELATED DISORDERS, & INFECTIOUS DISEASES DRIVING THE DEMAND FOR APOPTOSIS ASSAYS FOR CLINICAL & DIAGNOSTICS APPLICATIONS
9.4 BASIC RESEARCH
9.4.1 GROWING RESEARCH FUNDING FOR ACADEMIC INSTITUTIONS LIKELY TO SUPPORT THE DEMAND FOR APOPTOSIS ASSAYS IN BASIC RESEARCH
9.5 STEM CELL RESEARCH
9.5.1 RAPIDLY GROWING INTEREST IN REGENERATIVE THERAPIES DRIVING THE DEMAND FOR APOPTOSIS ASSAYS IN STEM CELL RESEARCH
10 APOPTOSIS ASSAYS MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 RISING R&D ACTIVITIES & INTEREST TOWARDS DEVELOPMENT OF APOPTOSIS TARGETED THERAPIES LIKELY TO DRIVE THE MARKET GROWTH AMONG PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 HOSPITAL & DIAGNOSTIC LABORATORIES
10.3.1 INCREASING NUMBER OF HOSPITALS & HIGH PREVALENCE OF CHRONIC DISEASES TO DRIVE THE MARKET GROWTH AMONG HOSPITAL & DIAGNOSTIC LABORATORIES
10.4 ACADEMIC & RESEARCH INSTITUTES
10.4.1 GROWING DRUG DISCOVERY RESEARCH IN ACADEMIC INSTITUTIONS TO PROPEL THE DEMAND FOR APOPTOSIS ASSAYS
11 APOPTOSIS ASSAYS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Increasing demand for early and effective disease diagnosis and treatment to drive the growth of the apoptosis assays market in the US
11.2.2 CANADA
11.2.2.1 Number of government initiatives to support life sciences research to drive the apoptosis assays market in Canada
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Well-established R&D infrastructure & large number of academic research institutes account for large share of Germany in European apoptosis assays market
11.3.2 FRANCE
11.3.2.1 Support from government and private investors for promoting research in cell therapy to drive the growth of the apoptosis assays market in France
11.3.3 UK
11.3.3.1 Growing prevalence of cancer and neurological disorders & increasing R&D investments to drive the demand for apoptosis assays in the UK
11.3.4 ITALY
11.3.4.1 Increasing prevalence of target diseases driving the demand for apoptosis assays in Italy
11.3.5 SPAIN
11.3.5.1 Increasing private and public funding for cell-based research to drive the growth of the apoptosis assays market in Spain
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 JAPAN
11.4.1.1 High prevalence of cancer and expansion of cancer research to drive the growth of the apoptosis assays market in Japan
11.4.2 CHINA
11.4.2.1 Increasing prevalence of chronic diseases and expanding biopharmaceutical research propelling the growth of the apoptosis assays market in China
11.4.3 INDIA
11.4.3.1 Geographic expansion of pharmaceutical companies and increasing cell-based research expected to drive the demand for apoptosis assays in India
11.4.4 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 INCREASING FUNDING FOR LIFE SCIENCES RESEARCH TO DRIVE THE DEMAND FOR APOPTOSIS ASSAYS IN LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 INCREASING NUMBER OF PARTNERSHIPS IN THE RESEARCH SECTOR DRIVING THE MARKET GROWTH IN THE MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.2.1 MARKET SHARE ANALYSIS: APOPTOSIS ASSAY KITS MARKET
12.3 COMPETITIVE SITUATION AND TRENDS
12.3.1 PRODUCT LAUNCHES
12.3.2 EXPANSIONS
12.3.3 ACQUISITIONS
12.3.4 OTHER STRATEGIES
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 MERCK KGAA
13.2 THERMO FISHER SCIENTIFIC INC.
13.3 BECTON, DICKINSON AND COMPANY
13.4 BIO-RAD LABORATORIES
13.5 PROMEGA CORPORATION
13.6 ABCAM PLC
13.7 BIO-TECHNE CORPORATION
13.8 SARTORIUS AG
13.9 BIOTIUM
13.10 CREATIVE BIOARRAY (A PART OF CREATIVE DYNAMICS INC.)
13.11 GENO TECHNOLOGY, INC.
13.12 GENECOPOEIA, INC.
13.13 DANAHER CORPORATION
13.14 GE HEALTHCARE
13.15 BIOTEK INSTRUMENTS
13.16 PERKINELMER
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 APOPTOSIS ASSAYS MARKET OVERVIEW
4.2 APOPTOSIS ASSAYS MARKET: GEOGRAPHIC OVERVIEW (2017)
4.3 REGIONAL MIX: APOPTOSIS ASSAYS MARKET (2018–2023)
4.4 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY END USER & COUNTRY (2017)
4.5 APOPTOSIS ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising incidence and prevalence of chronic and infectious diseases
5.2.1.2 Growing funding for cancer research
5.2.1.3 Growing cell-based research
5.2.1.4 Development of apoptosis-modulating drugs
5.2.2 RESTRAINTS
5.2.2.1 High investments required for research and development
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING ADOPTION OF APOPTOSIS-TARGETING THERAPY IN CANCER TREATMENT
6.2.2 TECHNOLOGICAL ADVANCEMENTS
6.2.2.1 Label-free detection and imaging of apoptosis
6.2.2.2 Microfluidic devices for the analysis of apoptosis
6.3 UNMET NEED
6.3.1 UNAVAILABILITY OF 3D APOPTOSIS ASSAYS
7 APOPTOSIS ASSAYS MARKET, BY PRODUCT
7.1 INTRODUCTION
7.1.1 ASSAY KITS
7.1.1.1 Caspase assays
7.1.1.1.1 Caspase assays to dominate the assay kits market during the forecast period
7.1.1.2 Annexin V and cell permeability assays
7.1.1.2.1 Annexin V & cell permeability assays are among the most commonly used apoptosis assays due to their ability to bind to phosphatidylserine
7.1.1.3 DNA fragmentation assays
7.1.1.3.1 Ability to detect nuclear changes to drive the demand for DNA fragmentation assay kits
7.1.1.4 Mitochondrial assays
7.1.1.4.1 Merck, Thermo Fisher, Bio-Rad, and BD are among the key players in the mitochondrial assays segment
7.1.2 REAGENTS
7.1.3 INSTRUMENTS
7.1.4 MICROPLATES
8 APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY
8.1 INTRODUCTION
8.1.1 FLOW CYTOMETRY
8.1.1.1 Flow cytometry is the most popular apoptosis detection technology owing to its ability to provide quantitative multi-parametric analysis
8.1.2 CELL IMAGING AND MICROSCOPY
8.1.2.1 Ability to monitor cell physiology and examine complex cellular processes to drive the demand for cell imaging and microscopy technologies
8.1.3 SPECTROPHOTOMETRY
8.1.3.1 Lower instrument cost as compared to flow cytometers drives greater adoption of spectrophotometers in academic settings
8.1.4 OTHER DETECTION TECHNOLOGIES
9 APOPTOSIS ASSAYS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 DRUG DISCOVERY AND DEVELOPMENT
9.2.1 DRUG DISCOVERY AND DEVELOPMENT FORMS THE LARGEST APPLICATION MARKET FOR APOPTOSIS ASSAYS
9.3 CLINICAL AND DIAGNOSTIC APPLICATIONS
9.3.1 RISING PREVALENCE OF CANCER, BLOOD-RELATED DISORDERS, & INFECTIOUS DISEASES DRIVING THE DEMAND FOR APOPTOSIS ASSAYS FOR CLINICAL & DIAGNOSTICS APPLICATIONS
9.4 BASIC RESEARCH
9.4.1 GROWING RESEARCH FUNDING FOR ACADEMIC INSTITUTIONS LIKELY TO SUPPORT THE DEMAND FOR APOPTOSIS ASSAYS IN BASIC RESEARCH
9.5 STEM CELL RESEARCH
9.5.1 RAPIDLY GROWING INTEREST IN REGENERATIVE THERAPIES DRIVING THE DEMAND FOR APOPTOSIS ASSAYS IN STEM CELL RESEARCH
10 APOPTOSIS ASSAYS MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 RISING R&D ACTIVITIES & INTEREST TOWARDS DEVELOPMENT OF APOPTOSIS TARGETED THERAPIES LIKELY TO DRIVE THE MARKET GROWTH AMONG PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 HOSPITAL & DIAGNOSTIC LABORATORIES
10.3.1 INCREASING NUMBER OF HOSPITALS & HIGH PREVALENCE OF CHRONIC DISEASES TO DRIVE THE MARKET GROWTH AMONG HOSPITAL & DIAGNOSTIC LABORATORIES
10.4 ACADEMIC & RESEARCH INSTITUTES
10.4.1 GROWING DRUG DISCOVERY RESEARCH IN ACADEMIC INSTITUTIONS TO PROPEL THE DEMAND FOR APOPTOSIS ASSAYS
11 APOPTOSIS ASSAYS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Increasing demand for early and effective disease diagnosis and treatment to drive the growth of the apoptosis assays market in the US
11.2.2 CANADA
11.2.2.1 Number of government initiatives to support life sciences research to drive the apoptosis assays market in Canada
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Well-established R&D infrastructure & large number of academic research institutes account for large share of Germany in European apoptosis assays market
11.3.2 FRANCE
11.3.2.1 Support from government and private investors for promoting research in cell therapy to drive the growth of the apoptosis assays market in France
11.3.3 UK
11.3.3.1 Growing prevalence of cancer and neurological disorders & increasing R&D investments to drive the demand for apoptosis assays in the UK
11.3.4 ITALY
11.3.4.1 Increasing prevalence of target diseases driving the demand for apoptosis assays in Italy
11.3.5 SPAIN
11.3.5.1 Increasing private and public funding for cell-based research to drive the growth of the apoptosis assays market in Spain
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 JAPAN
11.4.1.1 High prevalence of cancer and expansion of cancer research to drive the growth of the apoptosis assays market in Japan
11.4.2 CHINA
11.4.2.1 Increasing prevalence of chronic diseases and expanding biopharmaceutical research propelling the growth of the apoptosis assays market in China
11.4.3 INDIA
11.4.3.1 Geographic expansion of pharmaceutical companies and increasing cell-based research expected to drive the demand for apoptosis assays in India
11.4.4 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 INCREASING FUNDING FOR LIFE SCIENCES RESEARCH TO DRIVE THE DEMAND FOR APOPTOSIS ASSAYS IN LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 INCREASING NUMBER OF PARTNERSHIPS IN THE RESEARCH SECTOR DRIVING THE MARKET GROWTH IN THE MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET SHARE ANALYSIS
12.2.1 MARKET SHARE ANALYSIS: APOPTOSIS ASSAY KITS MARKET
12.3 COMPETITIVE SITUATION AND TRENDS
12.3.1 PRODUCT LAUNCHES
12.3.2 EXPANSIONS
12.3.3 ACQUISITIONS
12.3.4 OTHER STRATEGIES
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 MERCK KGAA
13.2 THERMO FISHER SCIENTIFIC INC.
13.3 BECTON, DICKINSON AND COMPANY
13.4 BIO-RAD LABORATORIES
13.5 PROMEGA CORPORATION
13.6 ABCAM PLC
13.7 BIO-TECHNE CORPORATION
13.8 SARTORIUS AG
13.9 BIOTIUM
13.10 CREATIVE BIOARRAY (A PART OF CREATIVE DYNAMICS INC.)
13.11 GENO TECHNOLOGY, INC.
13.12 GENECOPOEIA, INC.
13.13 DANAHER CORPORATION
13.14 GE HEALTHCARE
13.15 BIOTEK INSTRUMENTS
13.16 PERKINELMER
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
LIST OF TABLES
Table 1 APOPTOSIS ASSAYS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
Table 2 GLOBAL CANCER INCIDENCE
Table 3 APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 4 APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 5 APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 6 APOPTOSIS ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 7 LIST OF SOME OF THE CASPASE ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 8 CASPASE ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 LIST OF SOME OF THE ANNEXIN ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 10 ANNEXIN V AND CELL PERMEABILITY ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 LIST OF SOME OF THE DNA FRAGMENTATION ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 12 DNA FRAGMENTATION ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 13 LIST OF SOME OF THE MITOCHONDRIAL ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 14 MITOCHONDRIAL ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 APOPTOSIS REAGENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 16 APOPTOSIS INSTRUMENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 APOPTOSIS MICROPLATES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 18 APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 19 FLOW CYTOMETRY MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 20 CELL IMAGING AND MICROSCOPY MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 SPECTROPHOTOMETRY MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 22 OTHER DETECTION TECHNOLOGIES MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 24 APOPTOSIS ASSAYS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 APOPTOSIS ASSAYS MARKET FOR CLINICAL AND DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 26 APOPTOSIS ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 APOPTOSIS ASSAYS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 29 APOPTOSIS ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 30 APOPTOSIS ASSAYS MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 APOPTOSIS ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 32 APOPTOSIS ASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 33 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 37 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 38 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 39 US: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 40 US: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 41 US: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 42 US: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 43 US: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 44 CANADA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 45 CANADA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 46 CANADA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 47 CANADA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 48 CANADA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 49 EUROPE: APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 50 EUROPE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 51 EUROPE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 52 EUROPE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 53 EUROPE: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 54 EUROPE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 55 GERMANY: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 56 GERMANY: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 57 GERMANY: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 58 GERMANY: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 59 GERMANY: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 60 FRANCE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 61 FRANCE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 FRANCE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 63 FRANCE: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 64 FRANCE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 65 UK: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 66 UK: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 67 UK: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 68 UK: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 69 UK: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 70 ITALY: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 71 ITALY: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 ITALY: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 73 ITALY: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 74 ITALY: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 75 SPAIN: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 76 SPAIN: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 77 SPAIN: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 78 SPAIN: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 79 SPAIN: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 80 ROE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 81 ROE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 ROE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 83 ROE: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 84 ROE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 85 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 86 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 87 ASIA PACIFIC: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 88 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 89 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 90 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 91 JAPAN: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 92 JAPAN: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 JAPAN: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 94 JAPAN: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 95 JAPAN: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 96 CHINA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 97 CHINA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 98 CHINA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 99 CHINA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 100 CHINA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 101 INDIA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 102 INDIA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 103 INDIA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 104 INDIA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 105 INDIA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 106 ROAPAC: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 107 ROAPAC: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 ROAPAC: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 109 ROAPAC: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 110 ROAPAC: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 111 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 112 LATIN AMERICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 113 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 114 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 115 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 116 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 117 MIDDLE EAST & AFRICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 118 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 119 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 120 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 121 GROWTH STRATEGY MATRIX (2015–2018)
Table 122 PRODUCT LAUNCHES, 2015–2018
Table 123 EXPANSIONS, 2015–2018
Table 124 ACQUISITIONS, 2015–2018
Table 125 OTHER STRATEGIES, 2015–2018
Table 1 APOPTOSIS ASSAYS MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
Table 2 GLOBAL CANCER INCIDENCE
Table 3 APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 4 APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 5 APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 6 APOPTOSIS ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 7 LIST OF SOME OF THE CASPASE ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 8 CASPASE ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 9 LIST OF SOME OF THE ANNEXIN ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 10 ANNEXIN V AND CELL PERMEABILITY ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 11 LIST OF SOME OF THE DNA FRAGMENTATION ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 12 DNA FRAGMENTATION ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 13 LIST OF SOME OF THE MITOCHONDRIAL ASSAY KITS OFFERED BY PROMINENT PLAYERS
Table 14 MITOCHONDRIAL ASSAY KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 15 APOPTOSIS REAGENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 16 APOPTOSIS INSTRUMENTS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 17 APOPTOSIS MICROPLATES MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 18 APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 19 FLOW CYTOMETRY MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 20 CELL IMAGING AND MICROSCOPY MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 21 SPECTROPHOTOMETRY MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 22 OTHER DETECTION TECHNOLOGIES MARKET FOR APOPTOSIS DETECTION, BY COUNTRY, 2016–2023 (USD MILLION)
Table 23 APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 24 APOPTOSIS ASSAYS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2016–2023 (USD MILLION)
Table 25 APOPTOSIS ASSAYS MARKET FOR CLINICAL AND DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
Table 26 APOPTOSIS ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2016–2023 (USD MILLION)
Table 27 APOPTOSIS ASSAYS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2016–2023 (USD MILLION)
Table 28 APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 29 APOPTOSIS ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 30 APOPTOSIS ASSAYS MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 31 APOPTOSIS ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION)
Table 32 APOPTOSIS ASSAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 33 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 34 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 35 NORTH AMERICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 36 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 37 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 38 NORTH AMERICA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 39 US: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 40 US: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 41 US: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 42 US: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 43 US: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 44 CANADA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 45 CANADA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 46 CANADA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 47 CANADA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 48 CANADA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 49 EUROPE: APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 50 EUROPE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 51 EUROPE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 52 EUROPE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 53 EUROPE: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 54 EUROPE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 55 GERMANY: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 56 GERMANY: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 57 GERMANY: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 58 GERMANY: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 59 GERMANY: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 60 FRANCE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 61 FRANCE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 62 FRANCE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 63 FRANCE: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 64 FRANCE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 65 UK: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 66 UK: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 67 UK: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 68 UK: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 69 UK: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 70 ITALY: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 71 ITALY: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 72 ITALY: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 73 ITALY: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 74 ITALY: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 75 SPAIN: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 76 SPAIN: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 77 SPAIN: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 78 SPAIN: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 79 SPAIN: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 80 ROE: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 81 ROE: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 82 ROE: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 83 ROE: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 84 ROE: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 85 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
Table 86 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 87 ASIA PACIFIC: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 88 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 89 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 90 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 91 JAPAN: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 92 JAPAN: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 93 JAPAN: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 94 JAPAN: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 95 JAPAN: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 96 CHINA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 97 CHINA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 98 CHINA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 99 CHINA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 100 CHINA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 101 INDIA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 102 INDIA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 103 INDIA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 104 INDIA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 105 INDIA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 106 ROAPAC: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 107 ROAPAC: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 108 ROAPAC: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 109 ROAPAC: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 110 ROAPAC: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 111 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 112 LATIN AMERICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 113 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 114 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 115 LATIN AMERICA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 116 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
Table 117 MIDDLE EAST & AFRICA: APOPTOSIS ASSAY KITS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 118 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY DETECTION TECHNOLOGY, 2016–2023 (USD MILLION)
Table 119 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 120 MIDDLE EAST & AFRICA: APOPTOSIS ASSAYS MARKET, BY END USER, 2016–2023 (USD MILLION)
Table 121 GROWTH STRATEGY MATRIX (2015–2018)
Table 122 PRODUCT LAUNCHES, 2015–2018
Table 123 EXPANSIONS, 2015–2018
Table 124 ACQUISITIONS, 2015–2018
Table 125 OTHER STRATEGIES, 2015–2018
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 PRIMARY SOURCES
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 BOTTOM-UP APPROACH
Figure 5 TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 8 APOPTOSIS DETECTION TECHNOLOGY MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
Figure 9 APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 10 APOPTOSIS ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 11 GEOGRAPHICAL SNAPSHOT OF THE APOPTOSIS ASSAYS MARKET
Figure 12 RISING INCIDENCE AND PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES IS EXPECTED TO DRIVE MARKET GROWTH
Figure 13 THE US DOMINATED THE APOPTOSIS ASSAYS MARKET IN 2017
Figure 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018–2023)
Figure 15 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE APAC APOPTOSIS ASSAYS MARKET IN 2017
Figure 16 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
Figure 17 DRIVERS, RESTRAINTS, AND OPPORTUNITIES: APOPTOSIS ASSAYS MARKET
Figure 18 ASSAY KITS SEGMENT TO DOMINATE THE APOPTOSIS ASSAYS MARKET, BY PRODUCT, DURING THE FORECAST PERIOD
Figure 19 FLOW CYTOMETRY TO DOMINATE THE APOPTOSIS ASSAYS MARKET DURING THE FORECAST PERIOD
Figure 20 DRUG DISCOVERY AND DEVELOPMENT ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT IN THE APOPTOSIS ASSAYS MARKET IN 2018
Figure 21 APOPTOSIS ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 22 APOPTOSIS ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT (2017)
Figure 23 NORTH AMERICA TO DOMINATE THE APOPTOSIS ASSAYS MARKET DURING THE FORECAST PERIOD
Figure 24 NORTH AMERICA: APOPTOSIS ASSAYS MARKET SNAPSHOT
Figure 25 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET SNAPSHOT
Figure 26 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2015 TO MAY 2018
Figure 27 APOPTOSIS ASSAYS KITS MARKET, BY KEY PLAYER, 2017
Figure 28 MERCK KGAA: COMPANY SNAPSHOT (2017)
Figure 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
Figure 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
Figure 31 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017)
Figure 32 ABCAM PLC: COMPANY SNAPSHOT (2017)
Figure 33 BIO-TECHNE: COMPANY SNAPSHOT (2018)
Figure 34 SARTORIUS AG: COMPANY SNAPSHOT (2017)
Figure 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
Figure 36 GE HEALTHCARE: COMPANY SNAPSHOT (2017)
Figure 37 PERKINELMER: COMPANY SNAPSHOT (2017)
Figure 1 RESEARCH DESIGN
Figure 2 PRIMARY SOURCES
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 BOTTOM-UP APPROACH
Figure 5 TOP-DOWN APPROACH
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 APOPTOSIS ASSAYS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
Figure 8 APOPTOSIS DETECTION TECHNOLOGY MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
Figure 9 APOPTOSIS ASSAYS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
Figure 10 APOPTOSIS ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 11 GEOGRAPHICAL SNAPSHOT OF THE APOPTOSIS ASSAYS MARKET
Figure 12 RISING INCIDENCE AND PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES IS EXPECTED TO DRIVE MARKET GROWTH
Figure 13 THE US DOMINATED THE APOPTOSIS ASSAYS MARKET IN 2017
Figure 14 APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018–2023)
Figure 15 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE APAC APOPTOSIS ASSAYS MARKET IN 2017
Figure 16 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
Figure 17 DRIVERS, RESTRAINTS, AND OPPORTUNITIES: APOPTOSIS ASSAYS MARKET
Figure 18 ASSAY KITS SEGMENT TO DOMINATE THE APOPTOSIS ASSAYS MARKET, BY PRODUCT, DURING THE FORECAST PERIOD
Figure 19 FLOW CYTOMETRY TO DOMINATE THE APOPTOSIS ASSAYS MARKET DURING THE FORECAST PERIOD
Figure 20 DRUG DISCOVERY AND DEVELOPMENT ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT IN THE APOPTOSIS ASSAYS MARKET IN 2018
Figure 21 APOPTOSIS ASSAYS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
Figure 22 APOPTOSIS ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT (2017)
Figure 23 NORTH AMERICA TO DOMINATE THE APOPTOSIS ASSAYS MARKET DURING THE FORECAST PERIOD
Figure 24 NORTH AMERICA: APOPTOSIS ASSAYS MARKET SNAPSHOT
Figure 25 ASIA PACIFIC: APOPTOSIS ASSAYS MARKET SNAPSHOT
Figure 26 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2015 TO MAY 2018
Figure 27 APOPTOSIS ASSAYS KITS MARKET, BY KEY PLAYER, 2017
Figure 28 MERCK KGAA: COMPANY SNAPSHOT (2017)
Figure 29 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017)
Figure 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
Figure 31 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2017)
Figure 32 ABCAM PLC: COMPANY SNAPSHOT (2017)
Figure 33 BIO-TECHNE: COMPANY SNAPSHOT (2018)
Figure 34 SARTORIUS AG: COMPANY SNAPSHOT (2017)
Figure 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
Figure 36 GE HEALTHCARE: COMPANY SNAPSHOT (2017)
Figure 37 PERKINELMER: COMPANY SNAPSHOT (2017)
